Dr. Edgardo Jares

Médico. Facultad de Medicina. Universidad Nacional de Buenos Aires
Diploma de honor, Facultad de Medicina UBA
Residencia Completa en Clínica médica. Hospital Nacional Profesor Alejandro Posadas. Jefe de residentes de Clínica Médica
Especialista en Alergia e Inmunología, Secretaría de Estado de Salud Pública.
Miembro correspondiente de la American Academy of Allergy and Immunology.
Miembro de la European Academy of Allergy, Asthma and Immunology
Libros:
“Manual de Alergia a Medicamentos”, Editor, Buenos Aires 2009.
“Alergia Enfermedad Multisistémica, Fundamentos básicos y clínicos, Capítulo 16, Asma Ocupacional, Editorial Panamericana, México, julio 2008
Hipersensibilidad a medicamentos. Fundamentos y Manejo Clínico. Editorial Panamericana mayo 2017 https://www.medicapanamericana.com/Autores/Autor/21960/Edgardo-Jose-Jares.html

Artículos en Revistas científicas:
Trabajos publicados en revistas últimos 5 años:
Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol. 2014 Jul 24. pii: S1081-1206(14)00420-7. doi: 0.1016/j.anai.2014.06.019. [Epub ahead of print]
Comorbidities of asthma in the elderly in Argentina. World Allergy Organization Journal 2015 8(Suppl 1):A111.
Clinical characteristics of asthma in the elderly in Argentina. World Allergy Organization Journal 2015 8(Suppl 1):A108.
Drug-Induced Anaphylaxis in Latin American Countries. J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):780-8. doi: 10.1016/j.jaip.2015.05.012. Epub 2015 Jul 2.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation.Allergy. 2015 Jul 4. doi: 10.1111/all.12686. [Epub ahead of print
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016 Dec 30;6:47.
Registries as useful tools in characterization of allergic manifestations. Curr Opin Allergy Clin Immunol. 2016 Jun;16(3):250-6.
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy. 2016 Jul 29;6:29.
Surveying the new Allergic and hypersensitivity conditions chapter of the International Classification of Diseases (ICD)-11.Allergy. 2016 Sep;71(9):1235-40.
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
J Allergy Clin Immunol. 2016 Aug;138(2):367-374.
Angioedema associated with nonsteroidal anti-inflammatory drugs. Curr Opin Allergy Clin Immunol. 2016 Aug;16(4):323-32
The Jerusalem Chapter: A new paradigm in the care of allergic children and adolescents in Latin-American schools Rev Alerg Mex. 2017 Jan-Mar;64(1):3-6.
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) Clin Transl Allergy. 2017 Feb 20;7:5.
Why a registry of Chronic Urticaria (CUR) is needed. World Allergy Organ J. 2017 May 16;10(1):16.
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy. 2018 Jan;73(1):77-92.
[ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina]. Rev Alerg Mex. 2017 Jul-Sep;64(3):298-308.
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report. Clin Transl Allergy. 2017 Oct 23;7:37.
Clinical characteristics and comorbidities of elderly asthmatics who attend allergy clinics. Asthma Res Pract. 2018 Apr 23;4:5.
[Allergen extracts for immunotherapy in Latin America].
Rev Alerg Mex. 2018 Jan-Mar;65(1):25-40.
[2017 Brussels Agreement for Latin America: an initiative of the GARD and Slaai].
Rev Alerg Mex. 2018 Jul-Sep;65(3):217-221.
Controversies in drug allergy: In vitro testing. J Allergy Clin Immunol. 2019 Jan;143(1):56-65.
Drug hypersensitivity reactions in the Americas: Similarities and differences.
Ann Allergy Asthma Immunol. 2019 May;122(5):447-448.
MASK (Mobile Airways Sentinel Network). ARIA's comprehensive solution for mobile app for the multimorbidity of allergic rhinitis and asthma]. Rev Alerg Mex. 2019 Jan-Mar;66(1):140-146
[MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries]. Rev Alerg Mex. 2019 Apr-Jun;66(2):263-268
Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases-11. J Allergy Clin Immunol. 2019 Sep;144(3):627-633.
Latin American chronic urticaria registry (CUR) contribution to the understanding and knowledge of the disease in the region World Allergy Organ J. 2019 Jun 13;12(6)
[Clinical Practice Guide for Anaphylaxis in Latin America (Galaxia-Latam)].
Rev Alerg Mex. 2019;66 Suppl 2:1-39